Table 2

Reversal of MDS and cytogenetic abnormalities after HSCT

Patient no.Time point, yPretransplantation BM
Posttransplantation BM
Cellularity, %BM contentCytogeneticsCellularity, %BM contentCytogenetics
40-60 Atypical megakaryocytes, 10%-15% plasma cells Normal 40-60 Trilineage hematopoiesis, 8%-10% plasma cells Normal 
0.2 50 ↑Megakaryocytes, Dysplasia, ? clonal LGL ND 30 ↓ Megakaryocytes, hemophagocytic macrophages ND 
0.6 5-20 Markedly hypocellular with trilineage hypoplasia −Y 60 Normal marrow Normal 
0.6 30-60 ↓ Atypical megakaryocytes, focal ↑ blasts +8 40-50 Trilineage hematopoiesis Normal 
1.0 50-60 Atypical megakaryocytes, 10% myeloblasts −6 10-60 Few atypical megakaryocytes, < 5% blasts Normal 
0.6 40-60 Atypical megakaryocytes, mild dysplasia −7 10-20 Trilineage hypoplasia, no ↑ blasts Normal 
Patient no.Time point, yPretransplantation BM
Posttransplantation BM
Cellularity, %BM contentCytogeneticsCellularity, %BM contentCytogenetics
40-60 Atypical megakaryocytes, 10%-15% plasma cells Normal 40-60 Trilineage hematopoiesis, 8%-10% plasma cells Normal 
0.2 50 ↑Megakaryocytes, Dysplasia, ? clonal LGL ND 30 ↓ Megakaryocytes, hemophagocytic macrophages ND 
0.6 5-20 Markedly hypocellular with trilineage hypoplasia −Y 60 Normal marrow Normal 
0.6 30-60 ↓ Atypical megakaryocytes, focal ↑ blasts +8 40-50 Trilineage hematopoiesis Normal 
1.0 50-60 Atypical megakaryocytes, 10% myeloblasts −6 10-60 Few atypical megakaryocytes, < 5% blasts Normal 
0.6 40-60 Atypical megakaryocytes, mild dysplasia −7 10-20 Trilineage hypoplasia, no ↑ blasts Normal 

MDS indicates myelodysplastic syndrome; ND, not done; and LGL, large granular lymphocyte.

Close Modal

or Create an Account

Close Modal
Close Modal